Lucy Scientific Discovery Announces Proposal to Acquire Pasithea Therapeutics For $0.60 Per Share In Cash And $0.25/Share In Lucy Stock
Portfolio Pulse from Benzinga Newsdesk
Lucy Scientific Discovery (LSDI) has proposed to acquire Pasithea Therapeutics (KTTA) for $0.60 per share in cash and $0.25 per share in LSDI stock.
June 05, 2023 | 1:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pasithea Therapeutics is proposed to be acquired by Lucy Scientific Discovery for $0.60 per share in cash and $0.25 per share in LSDI stock, potentially impacting KTTA's stock price.
The proposed acquisition of Pasithea Therapeutics by Lucy Scientific Discovery may lead to an increase in KTTA's stock price in the short term, as the offer of $0.60 per share in cash and $0.25 per share in LSDI stock may be viewed as favorable by investors.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Lucy Scientific Discovery proposes to acquire Pasithea Therapeutics, which may impact LSDI's stock price in the short term.
The proposed acquisition of Pasithea Therapeutics by Lucy Scientific Discovery may lead to an increase in LSDI's stock price in the short term, as investors may view the acquisition as a positive development for the company's growth and expansion.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100